Special Collection on Biomarkers in a ‘One Health’ context

To have your paper considered for this Special Collection, submit by March 31, 2020.

Please review the Manuscript Submission Guidelines before submitting your article. 

Click here to submit your paper.

Guest Editor:

Fernando Manuel Salvado Capela e Silva, PhD
University of Évora, Portugal
[email protected]

Overview

According to the One Health concept, people's health is closely linked to animal health and the environment. Thus, in order to achieve better general and global health outcomes, the concept of One Health is based on a multidisciplinary, interdisciplinary, and transdisciplinary approach.

When it comes to infectious diseases, this parallelism is prone to be even more important, for as much as 75% of all emerging diseases are believed to be zoonotic. Examples of successful use of biomarkers have been found in several zoonotic diseases such as Ebola, dengue, leptospirosis or West Nile virus infections. In the areas of the non-notifiable diseases, humans and animals are found to be subject to the same environmental and genetic predisposing factors. As an example, the existence of mutations in the BR-CA1 gene predisposing to breast cancer, both in humans and in dogs, with increased prevalence in certain dog breeds and human ethnic groups.

Biomarkers are defined as measurable biochemical indicators of the presence of disease or as indicators for monitoring probability of its occurrence, development and progression. Biomarkers have been used in several domains such as oncology, neurology, cardiovascular, inflammatory and respiratory disease, and in several endocrinopathies. Bridging biomarkers in a One Health perspective has been proven useful in all of these domains. For example, Acute Phase Proteins (APPs) have been used for quite some time as biomarkers of inflammatory conditions. These have been used in human and veterinary health, such as in mastitis evaluation and PRRS (porcine respiratory and reproductive syndrome) diagnosis.

Thus, research on the discovery and study of new biomarkers in the One Health context is a promising approach to understanding the etiology and pathophysiology of many diseases affecting humans and animals.

Topics of interest include, but are not limited to:

1. Biomarkers in One Health Studies

2. Public Health

3. Human and Animal Models for Translational Research/Medicine

4. Biomarkers of Emergent Infectious Diseases (and Zoonotic)

5. Biomarkers of Non-communicable Diseases

6. Microbiome Biomarkers

7. Behavioral Biomarkers

8. Welfare and Stress Biomarkers

9. The Importance of Animals as Sentinels

The submitted manuscripts for this Special Collection will be peer-reviewed before publication.

Submit your paper.

Please submit your paper according to the following timetable for the Special Collection:

Submission Deadline

March 31, 2020

An article processing charge may apply upon acceptance of your paper. 

Guest Editor:

Fernando Manuel Salvado Capela e Silva, PhD
Fernando Capela e Silva holds a PhD in Biology from the University of Évora since 2004. He is a Professor of Animal Histology and Embriology in the MSc in Veterinary Medicine and Human Histology in the BSc of Human Biology. He is a member of Institute of Mediterranean Agricultural and Environmental Sciences (ICAAM; http://www.icaam.uevora.pt/). His present research interests include: Comparative animal cytology and histology. Functional morphology and adaptive processes. Tissues homeostasis and biomarkers of tissue function, injury and repair. Oral Biology: Effects of external and internal factors on morphophysiological adaptations of oral tissues.